This stock is no longer traded. It was delisted on July 8, 2026. Prices stop on that date; discussion is still counted.
Generated by AI
BIMI Holdings Inc. is a healthcare products and services provider specializing in the retail and wholesale distribution of medical devices, pharmaceuticals, and various healthcare-related products. Headquartered in New York, the company primarily operates in the People’s Republic of China, with four core business segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. Its wholesale pharmaceutical division provides both prescription and over-the-counter medicines, including traditional Chinese medicines, to clinics, hospitals, and drug stores. The medical devices segment features distribution of high-profile items such as Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic equipment to healthcare institutions in Southwest China. Through its retail pharmacy arm, BIMI Holdings offers a diverse portfolio under proprietary brands including Lijiantang Pharmacy, serving end consumers directly. The company’s reach also extends to medical services, operating private hospitals and offering IT R&D solutions for healthcare institutions. BIMI Holdings Inc. plays a significant role in facilitating access to modern and traditional healthcare products, supporting both clinical infrastructure and patient care within China’s evolving health sector.
Website725 5th Avenue
New York, NY, 10022
United States
Summary of Aug 21's posts. Generated by AI.
Summary of Aug 20's posts. Generated by AI.
Summary of May 24's posts. Generated by AI.
Investors talking about BIMI also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.